(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 8.58%11.87B | 8.98%7.99B | 8.99%5.43B | 4.73%2.31B | 4.49%10.93B | 3.87%7.33B | 6.83%4.98B | 12.98%2.21B | 16.12%10.46B | 23.21%7.06B |
Operating income | 8.58%11.87B | 8.98%7.99B | 8.99%5.43B | 4.73%2.31B | 4.49%10.93B | 3.87%7.33B | 6.83%4.98B | 12.98%2.21B | 16.12%10.46B | 23.21%7.06B |
Operating expenses | -6.36%-7.35B | -6.84%-5.12B | -7.67%-3.32B | -4.82%-1.56B | -4.01%-6.91B | -7.76%-4.79B | -12.00%-3.08B | -26.54%-1.49B | -21.88%-6.65B | -28.36%-4.44B |
Gross profit | 12.40%4.52B | 12.99%2.87B | 11.14%2.11B | 4.54%746.72M | 5.34%4.02B | -2.74%2.54B | -0.64%1.9B | -7.70%714.26M | 7.29%3.81B | 15.35%2.62B |
Selling expenses | -15.78%-1.4B | -9.71%-909.52M | -4.99%-660.59M | -2.35%-214.37M | -8.07%-1.21B | 12.07%-829.05M | 10.04%-629.21M | 13.18%-209.46M | 5.35%-1.12B | -19.38%-942.79M |
Administrative expenses | -15.42%-1.62B | -15.91%-1.05B | -20.58%-717.78M | -13.17%-319.22M | 3.54%-1.4B | 3.83%-906.03M | 0.22%-595.3M | -1.54%-282.07M | -20.63%-1.45B | -19.08%-942.16M |
Research and development expenses | -41.03%-19.98M | -94.13%-12.91M | -273.32%-8.67M | -204.86%-3.75M | -273.42%-14.17M | -189.64%-6.65M | -77.32%-2.32M | -188.72%-1.23M | -24.85%-3.79M | -96.99%-2.3M |
Profit from asset sales | -94.62%2.18M | -98.61%561.75K | -99.34%267.76K | -71.80%42.96K | 1,905.97%40.43M | 1,920.74%40.42M | 1,889.42%40.34M | -92.14%152.33K | 690.39%2.02M | 1,011.23%2M |
Revaluation surplus | 57.81%-57.01M | 92.23%-11.58M | 91.88%-4.64M | 107.51%4.11M | -288.51%-135.14M | -133.12%-149.05M | -54.90%-57.14M | -8.50%-54.82M | -29.46%71.69M | -161.88%-63.94M |
-Changes in the fair value of other assets | 57.81%-57.01M | 92.23%-11.58M | 91.88%-4.64M | 107.51%4.11M | -288.51%-135.14M | -133.12%-149.05M | -54.90%-57.14M | -8.50%-54.82M | -29.46%71.69M | -161.88%-63.94M |
Impairment and provision | 14.25%-156.95M | 11.46%-139.78M | 5.78%-124.99M | 13.35%-45.44M | -1.43%-183.03M | -65.84%-157.86M | -37.91%-132.66M | 21.31%-52.44M | 15.33%-180.45M | 47.53%-95.19M |
-Other impairment is provision | 14.25%-156.95M | 11.46%-139.78M | 5.78%-124.99M | 13.35%-45.44M | -1.43%-183.03M | -65.84%-157.86M | -37.91%-132.66M | 21.31%-52.44M | 15.33%-180.45M | 47.53%-95.19M |
Special items of operating profit | -27.89%145.98M | -2.98%147.1M | 12.26%157.92M | 219.85%15.6M | 4.77%202.45M | 39.97%151.62M | 28.85%140.68M | -85.41%-13.01M | -26.10%193.24M | -34.11%108.33M |
Operating profit | 8.18%1.38B | 33.87%882.87M | 15.83%742M | 87.59%179.02M | -0.31%1.27B | 1.01%659.5M | 12.22%640.59M | -24.54%95.43M | 0.95%1.28B | -12.14%652.87M |
Financing cost | 59.83%229.26M | 17.51%127.33M | 6.33%73.49M | -7.72%40.25M | 78.44%143.44M | 95.25%108.36M | 111.32%69.11M | 90.11%43.62M | 75.44%80.38M | 43.34%55.5M |
Special items of earning before tax | -18.31%-41.26M | -17.95%-19.72M | -63.91%-13.98M | -140.08%-5.25M | 25.63%-34.88M | 19.67%-16.72M | 35.96%-8.53M | 749.07%13.1M | 19.00%-46.89M | -11.98%-20.82M |
Earning before tax | 13.29%1.56B | 31.86%990.47M | 14.31%801.52M | 40.66%214.02M | 5.43%1.38B | 9.25%751.13M | 18.80%701.18M | 3.23%152.15M | 4.60%1.31B | -9.91%687.55M |
Tax | 469.97%65.18M | -156.08%-11.07M | -191.68%-12.61M | -162.03%-9.42M | 309.72%11.44M | 17.76%19.74M | 43.30%13.75M | 42.45%15.18M | 33.26%-5.45M | 190.57%16.76M |
After-tax profit from continuing operations | 17.04%1.63B | 27.05%979.4M | 10.35%788.91M | 22.27%204.6M | 6.75%1.39B | 9.45%770.87M | 19.19%714.93M | 5.87%167.34M | 4.85%1.3B | -5.42%704.31M |
Earning after tax | 17.04%1.63B | 27.05%979.4M | 10.35%788.91M | 22.27%204.6M | 6.75%1.39B | 9.45%770.87M | 19.19%714.93M | 5.87%167.34M | 4.85%1.3B | -5.42%704.31M |
Minority profit | 1,004.83%49.2M | 2,639.11%38.93M | 1,033.41%26.75M | 372.02%4.97M | -104.42%-5.44M | 51.25%-1.53M | 7.29%-2.87M | -212.11%-1.83M | 86.55%-2.66M | 77.20%-3.15M |
Profit attributable to shareholders | 13.06%1.58B | 21.76%940.47M | 6.18%762.16M | 18.01%199.63M | 6.95%1.4B | 9.18%772.4M | 19.06%717.8M | 8.15%169.16M | 3.42%1.31B | -6.73%707.46M |
Basic earnings per share | 13.27%1.28 | 20.63%0.76 | 6.90%0.62 | 14.29%0.16 | 6.60%1.13 | 10.53%0.63 | 18.37%0.58 | 7.69%0.14 | 3.92%1.06 | -6.56%0.57 |
Diluted earnings per share | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | -- | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | -- | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data